The effect of intraurethral heparin on inflammation and spongiofibrosis in a rat model of experimentally induced urethral trauma
- 28 April 2023
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 55 (6) , 1421-1426
Abstract
Aim To determine the effect of heparin administered during the early post urethral trauma period on inflammation and spongiofibrosis in rats. Materials and methods The study included 24 male rats that were randomized into 3 groups of 8 each. The urethra was traumatized using a 24-G needle sheath in all rats. Group 1 (control group) received intraurethral saline 0.9% injected b.i.d. for 27 days, group 2 received intraurethral Na-heparin (liquemine-Roche) 1500 IU kg−1 injected b.i.d. for 27 days, and group 3 received intraurethral Na-heparin 1500 IU kg−1 injected b.i.d and saline 0.9% s.i.d. for 27 days. On day 28 the rats’ penises were degloved and penectomy was performed. Inflammation, spongiofibrosis, and congestion in the urethra were investigated in each group. Results A statistically significant difference was found between the three groups (control, heparin, and heparin + saline) in the histopathological status of spongiofibrosis, inflammation, and congestion, respectively (P = 0.0001, P = 0.002, P = 0.0001). Severe spongiofibrosis was observed in six (75%) of the rats in group 1 (control group), whereas severe spongiofibrosis was not observed in group 2 (heparin) or group 3 (heparin + saline). Conclusion We observed that intraurethral Na-heparin 1500 IU kg−1 injectioned during the early posturethral trauma period in rats significantly decreased inflammation, spongiofibrosis, and congestion.Keywords
This publication has 25 references indexed in Scilit:
- Strategies for anti-fibrotic therapiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2013
- Nebulized anticoagulants for acute lung injury - a systematic review of preclinical and clinical investigationsCritical Care, 2012
- Non-anticoagulant Effects of Heparin: An Overview2011
- Inhalable Liposomes of Low Molecular Weight Heparin for the Treatment of Venous ThromboembolismJournal of Pharmaceutical Sciences, 2010
- Nebulised heparin: a new approach to the treatment of acute lung injury?Critical Care, 2008
- Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the ratJournal of Hepatology, 2007
- Complications of Transurethral Resection of the Prostate (TURP)—Incidence, Management, and PreventionEuropean Urology, 2006
- Inhaled heparin in cystic fibrosisEuropean Respiratory Journal, 2006
- Effects of low molecular weight heparin in obstructed kidneys: decrease of collagen, fibronectin and TGF-β, and increase of chondroitin/dermatan sulfate proteoglycans and macrophage infiltrationNephrology Dialysis Transplantation, 2006
- Antitumor and antimetastatic effect of warfarin and heparinsBiomedicine & Pharmacotherapy, 2004